Isonaringin | CAS 108815-81-2 - Request Quote
Isonaringin
| SZ CAT No: | SZ-N043002 |
| CAS No | 108815-81-2 |
| Mol.F. | C27H32O14 |
| Mol.Wt. | 580.5 |
| Inv. Status | In Stock |
| Shipping Condition | Room Temperature |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Isonaringin is chemically 5-Hydroxy-2-(4-hydroxyphenyl)-7-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-((((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)chroman-4-one. Isonaringin is supplied with detailed characterization data compliant with regulatory guideline. Isonaringin can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Narirutin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 108815-81-2
Purchase 108815-81-2
Order 108815-81-2
Enquire 108815-81-2
price of 108815-81-2
108815-81-2 Supplier
108815-81-2 Manufacturer
108815-81-2 Exporter
buy high quality Isonaringin
Purchase Isonaringin
Isonaringin suppliers
Isonaringin manufacturers
Isonaringin price
Order Isonaringin
Enquire Isonaringin
Isonaringin cost
Isonaringin Supplier
Isonaringin Distributor
Isonaringin for Method Validation
Narirutin Reference Standard
Isonaringin for ANDA Filing
Isonaringin for Forced Degradation Studies
Isonaringin Identification Standards
Isonaringin for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


